|
1
|
Torres T, Ferreira EO, Gonçalo M,
Mendes-Bastos P, Selores M and Filipe P: Update on atopic
dermatitis. Acta Med Port. 32:606–613. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cabanillas B, Brehler AC and Novak N:
Atopic dermatitis phenotypes and the need for personalized
medicine. Curr Opin Allergy Clin Immunol. 17:309–315.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Suárez-Fariñas M, Dhingra N, Gittler J,
Shemer A, Cardinale I, de Guzman Strong C, Krueger JG and
Guttman-Yassky E: Intrinsic atopic dermatitis shows similar TH2 and
higher TH17 immune activation compared with extrinsic atopic
dermatitis. J Allergy Clin Immunol. 132:361–370. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Leung DY, Nicklas RA, Li JT, Bernstein IL,
Blessing-Moore J, Boguniewicz M, Chapman JA, Khan DA, Lang D, Lee
RE, et al: Disease management of atopic dermatitis: An updated
practice parameter. Joint Task Force on Practice Parameters. Ann
Allergy Asthma Immunol. 93 (3 Suppl 2):S1–S21. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kim HS, Lee JH, Roh KH, Jun HJ, Kang KS
and Kim TY: Clinical trial of human umbilical cord blood-derived
stem cells for the treatment of moderate-to-severe atopic
dermatitis: Phase I/IIa studies. Stem Cells. 35:248–255.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Schneider L, Tilles S, Lio P, Boguniewicz
M, Beck L, LeBovidge J, Novak N, Bernstein D, Blessing-Moore J,
Khan D, et al: Atopic dermatitis: A practice parameter update 2012.
J Allergy Clin Immunol. 131:295–299.e1-27. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Silverberg NB and Duran-McKinster C:
Special considerations for therapy of pediatric atopic dermatitis.
Dermatol Clin. 35:351–363. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Huo J, Zhang L, Ren X, Li C, Li X, Dong P,
Zheng X, Huang J, Shao Y, Ge M, et al: Multifaceted
characterization of the signatures and efficacy of mesenchymal
stem/stromal cells in acquired aplastic anemia. Stem Cell Res Ther.
11(59)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shi Y and Wang Y, Li Q, Liu K, Hou J, Shao
C and Wang Y: Immunoregulatory mechanisms of mesenchymal stem and
stromal cells in inflammatory diseases. Nat Rev Nephrol.
14:493–507. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Menasche P: Cell therapy trials for heart
regeneration-lessons learned and future directions. Nat Rev
Cardiol. 15:659–671. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Matas J, Orrego M, Amenabar D, Infante C,
Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, González PL, Muse
E, Khoury M, et al: Umbilical cord-derived mesenchymal stromal
cells (MSCs) for knee osteoarthritis: Repeated MSC dosing is
superior to a single MSC dose and to hyaluronic acid in a
controlled randomized phase I/II trial. Stem Cells Transl Med.
8:215–224. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hidalgo Perea S, Lyons LP, Nishimuta JF,
Weinberg JB and McNulty AL: Evaluation of culture conditions for in
vitro meniscus repair model systems using bone marrow-derived
mesenchymal stem cells. Connect Tissue Res. 61:322–337.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Reza-Zaldivar EE, Hernández-Sapiéns MA,
Minjarez B, Gutiérrez-Mercado YK, Márquez-Aguirre AL and
Canales-Aguirre AA: Potential effects of MSC-derived exosomes in
neuroplasticity in Alzheimer's disease. Front Cell Neurosci.
12(317)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu GH, Shi HJ, Che MT, Huang MY, Wei QS,
Feng B, Ma YH, Wang LJ, Jiang B, Wang YQ, et al: Recovery of
paralyzed limb motor function in canine with complete spinal cord
injury following implantation of MSC-derived neural network tissue.
Biomaterials. 181:15–34. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Huang B, Cheng X, Wang H, Huang W, la Ga
Hu Z, Wang D, Zhang K, Zhang H, Xue Z, Da Y, et al: Mesenchymal
stem cells and their secreted molecules predominantly ameliorate
fulminant hepatic failure and chronic liver fibrosis in mice
respectively. J Transl Med. 14(45)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lin BL, Chen JF, Qiu WH, Wang KW, Xie DY,
Chen XY, Liu QL, Peng L, Li JG, Mei YY, et al: Allogeneic bone
marrow-derived mesenchymal stromal cells for hepatitis B
virus-related acute-on-chronic liver failure: A randomized
controlled trial. Hepatology. 66:209–219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang L, Liu T, Liang R, Wang G, Liu Y, Zou
J, Liu N, Zhang B, Liu Y, Ding X, et al: Mesenchymal stem cells
ameliorate beta cell dysfunction of human type 2 diabetic islets by
reversing beta cell dedifferentiation. EBioMedicine.
51(102615)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li B, Luan S, Chen J, Zhou Y, Wang T, Li
Z, Fu Y, Zhai A and Bi C: The MSC-derived exosomal lncRNA H19
promotes wound healing in diabetic foot ulcers by upregulating PTEN
via MicroRNA-152-3p. Mol Ther Nucleic Acidrs. 19:814–826.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ding L, Yan G, Wang B, Xu L, Gu Y, Ru T,
Cui X, Lei L, Liu J, Sheng X, et al: Transplantation of UC-MSCs on
collagen scaffold activates follicles in dormant ovaries of POF
patients with long history of infertility. Sci China Life Sci.
61:1554–1565. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu F, Hu S, Yang H, Li Z, Huang K, Su T,
Wang S and Cheng K: Hyaluronic acid hydrogel integrated with
mesenchymal stem cell-secretome to treat endometrial injury in a
rat model of Asherman's syndrome. Adv Healthc Mater.
8(e1900411)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wei Y, Zhang L, Chi Y, Ren X, Gao Y, Song
B, Li C and Han Z, Zhang L and Han Z: High-efficient generation of
VCAM-1(+) mesenchymal stem cells with multidimensional
superiorities in signatures and efficacy on aplastic anaemia mice.
Cell Prolif: e12862, 2020.
|
|
22
|
Song K, Li W and Li M: Acute promyelocytic
leukemia following autologous bone marrow-derived mesenchymal stem
cell transplantation for traumatic brain injury: A case report.
Oncol Lett. 10:2905–2908. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhao Q, Zhang L, Wei Y, Yu H, Zou L, Huo
J, Yang H, Song B, Wei T, Wu D, et al: Systematic comparison of
hUC-MSCs at various passages reveals the variations of signatures
and therapeutic effect on acute graft-versus-host disease. Stem
Cell Res Ther. 10(354)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hou H, Zhang L, Duan L, Liu Y, Han Z, Li Z
and Cao X: Spatio-temporal metabolokinetics and efficacy of human
placenta-derived mesenchymal stem/stromal cells on mice with
refractory Crohn's-like enterocutaneous fistula. Stem Cell Rev Rep.
16:1292–1304. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Golchin A, Seyedjafari E and
Ardeshirylajimi A: Mesenchymal Stem Cell Therapy for COVID-19:
Present or Future. Stem Cell Rev Rep. 16:427–433. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kabat M, Bobkov I, Kumar S and Grumet M:
Trends in mesenchymal stem cell clinical trials 2004-2018: Is
efficacy optimal in a narrow dose. range? Stem Cells Transl Med.
9:17–27. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Guttman-Yassky E, Nograles KE and Krueger
JG: Contrasting pathogenesis of atopic dermatitis and
psoriasis-part II: Immune cell subsets and therapeutic concepts. J
Allergy Clin Immunol. 127:1420–1432. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Beck LA, Thaçi D, Hamilton JD, Graham NM,
Bieber T, Rocklin R, Ming JE, Ren H, Kao R, Simpson E, et al:
Dupilumab treatment in adults with moderate-to-severe atopic
dermatitis. N Engl J Med. 371:130–139. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ou Z, Chen C, Chen A, Yang Y and Zhou W:
Adverse events of Dupilumab in adults with moderate-to-severe
atopic dermatitis: A meta-analysis. Int Immunopharmacol.
54:303–310. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Blauvelt A, de Bruin-Weller M, Gooderham
M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC,
Rubel D, et al: Long-term management of moderate-to-severe atopic
dermatitis with dupilumab and concomitant topical corticosteroids
(LIBERTY AD CHRONOS): A 1-year, randomised, double-blinded,
placebo-controlled, phase 3 trial. Lancet. 389:2287–2303.
2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cho J, D'Antuono M, Glicksman M, Wang J
and Jonklaas J: A review of clinical trials: Mesenchymal stem cell
transplant therapy in type 1 and type 2 diabetes mellitus. Am J
Stem Cells. 7:82–93. 2018.PubMed/NCBI
|
|
32
|
Gonzaga VF, Wenceslau CV, Lisboa GS, Frare
EO and Kerkis I: Mesenchymal stem cell benefits observed in bone
marrow failure and acquired aplastic anemia. Stem Cells Int.
2017(8076529)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dalal J, Gandy K and Domen J: Role of
mesenchymal stem cell therapy in Crohn's disease. Pediatr Res.
71:445–451. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pourgholaminejad A, Aghdami N, Baharvand H
and Moazzeni SM: The effect of pro-inflammatory cytokines on
immunophenotype, differentiation capacity and immunomodulatory
functions of human mesenchymal stem cells. Cytokine. 85:51–60.
2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wei Y, Hou H, Zhang L, Zhao N, Li C, Huo
J, Liu Y, Zhang W, Li Z, Liu D, et al: JNKi- and DAC-programmed
mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis
and alleviate hind limb ischemia. Stem Cell Res Ther.
10(186)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yao J, Chen N, Wang X, Zhang L, Huo J, Chi
Y, Li Z and Han Z: Human supernumerary teeth-derived apical
papillary Stem Cells possess preferable characteristics and
efficacy on hepatic fibrosis in mice. Stem Cells Int.
2020(6489396)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Du W, Li X, Chi Y, Ma F, Li Z, Yang S,
Song B, Cui J, Ma T, Li J, et al: VCAM-1+ placenta
chorionic villi-derived mesenchymal stem cells display potent
pro-angiogenic activity. Stem Cell Res Ther. 7(49)2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fan XL, Zhang Y, Li X and Fu QL:
Mechanisms underlying the protective effects of mesenchymal stem
cell-based therapy. Cell Mol Life Sci. 77:2771–2794.
2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kfoury Y and Scadden DT: Mesenchymal cell
contributions to the stem cell niche. Cell Stem Cell. 16:239–253.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim HS, Yun JW, Shin TH, Lee SH, Lee BC,
Yu KR, Seo Y, Lee S, Kang TW, Choi SW, et al: Human umbilical cord
blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate
atopic dermatitis by reducing mast cell degranulation. Stem Cells.
33:1254–1266. 2015.PubMed/NCBI View Article : Google Scholar
|
